Nuclear receptor related 1 (Nurr1) is a promising target for neuroprotection in diseases like Parkinson’s and Alzheimer’s, yet its activation mechanism by synthetic ligands remains unclear. This evidence concerns the gene NR4A2 and Parkinsonism.